January’s top news stories

January’s top news stories

A Phase I clinical trial of monoclonal antibody (mAb) CIS43LS against malaria started the enrolment...

November’s top news stories

November’s top news stories

Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether...

October’s top news stories

October’s top news stories

GSK has initiated the Phase III EAGLE programme of gepotidacin for the treatment of uncomplicated...

August’s top news stories

August’s top news stories

Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet...

June’s top news stories

June’s top news stories

AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial...

May’s top news stories

May’s top news stories

Novartis reported that the first clinical trial in its Phase III PLATINUM programme for QMF149...

April’s top news stories

April’s top news stories

Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech company MorphoSys have begun the first...

March’s top news stories

March’s top news stories

Aldeyra Therapeutics reported positive data from the Phase III ALLEVIATE trial that evaluated the efficacy...